Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001140361-17-032844
Filing Date
2017-08-21
Accepted
2017-08-21 15:51:35
Documents
1
Effectiveness Date
2017-08-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10848
  Complete submission text file 0001140361-17-032844.txt   12057
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-275461 | Film No.: 171043113